by Savitha C Muppala on  April 30, 2011 at 2:17 AM Drug News
 Avastin , the Cancer Drug Brings Hope as a Cost-effective Treatment for AMD
A recent study compared the performance of Avastin, a cancer treatment drug and Ludentis, a drug used to treat a degenerative eye disease, which showed that both drugs performed with the same level of efficiency in treating age-related macular degeneration.  

Patients who received monthly doses of Avastin were benefitted by a 8.0 letters of visual acuity as compared to an 8.5 letter improvement produced by the drug Ludentis.

Both drugs are manufactured by the same company, Genentech, but are differently priced.

While a single dose of Avastin costs about $50, patients will have to cough up so much more for a single dose of Ludentis, priced at about $2,000.

Source: Medindia

Most Popular on Medindia